BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18800608)

  • 1. [Role of NK cell receptor-expressing cells in the regulation of GVHD and GVL].
    Tanaka J
    Rinsho Ketsueki; 2008 Aug; 49(8):598-606. PubMed ID: 18800608
    [No Abstract]   [Full Text] [Related]  

  • 2. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.
    Bishara A; De Santis D; Witt CC; Brautbar C; Christiansen FT; Or R; Nagler A; Slavin S
    Tissue Antigens; 2004 Mar; 63(3):204-11. PubMed ID: 14989709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of killer cell immunoglobulin-like receptor genotypes on acute graft-vs-host disease after unrelated hematopoietic stem cell transplantation in Koreans.
    Kim SY; Choi HB; Yoon HY; Choi EJ; Cho B; Kim HK; Kim YJ; Kim HJ; Min CK; Kim DW; Lee JW; Min WS; Kim CC; Kim TG
    Tissue Antigens; 2007 Apr; 69 Suppl 1():114-7. PubMed ID: 17445182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Target antigens for graft-versus-host disease (GVHD) and graft-versus-leukemia/tumor (GVL/T)].
    Tanaka J
    Nihon Rinsho; 2003 Sep; 61(9):1512-9. PubMed ID: 14515717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunology. A perfect mismatch.
    Kärre K
    Science; 2002 Mar; 295(5562):2029-31. PubMed ID: 11896262
    [No Abstract]   [Full Text] [Related]  

  • 7. Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation.
    Ruggeri L; Mancusi A; Burchielli E; Perruccio K; Aversa F; Martelli MF; Velardi A
    Semin Cancer Biol; 2006 Oct; 16(5):404-11. PubMed ID: 16916611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation.
    Ruggeri L; Capanni M; Mancusi A; Urbani E; Perruccio K; Burchielli E; Tosti A; Topini F; Aversa F; Martelli MF; Velardi A
    Blood Cells Mol Dis; 2004; 33(3):216-21. PubMed ID: 15528134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias.
    Moretta A; Locatelli F; Moretta L
    Immunol Rev; 2008 Aug; 224():58-69. PubMed ID: 18759920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactive killer cells: hindrance and help for haematopoietic transplants.
    Parham P; McQueen KL
    Nat Rev Immunol; 2003 Feb; 3(2):108-22. PubMed ID: 12563295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer receptors and graft-vs.-host/ graft-vs.-leukaemia reactions.
    Jones DC; Young NT
    Vox Sang; 2004 Jul; 87 Suppl 2():15-7. PubMed ID: 15209869
    [No Abstract]   [Full Text] [Related]  

  • 12. Alloreactive natural killer cells in hematopoietic stem cell transplantation.
    Pegram HJ; Ritchie DS; Smyth MJ; Wiernik A; Prince HM; Darcy PK; Kershaw MH
    Leuk Res; 2011 Jan; 35(1):14-21. PubMed ID: 20719383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation.
    Malmberg KJ; Schaffer M; Ringdén O; Remberger M; Ljunggren HG
    Mol Immunol; 2005 Feb; 42(4):531-4. PubMed ID: 15607809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cells: biology and clinical use in cancer therapy.
    Hallett WH; Murphy WJ
    Cell Mol Immunol; 2004 Feb; 1(1):12-21. PubMed ID: 16212916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of alloreactive KIR2DS1(+) NK cells in haploidentical hematopoietic stem cell transplantation.
    Marcenaro E; Carlomagno S; Pesce S; Della Chiesa M; Moretta A; Sivori S
    J Leukoc Biol; 2011 Oct; 90(4):661-7. PubMed ID: 21791599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activating killer cell immunoglobulin-like receptors as important determinants of acute graft-versus host disease in hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ; Choi Y; Min WS; Kim TG; Cho BS; Kim SY; Eom KS; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Kim CC
    Transplantation; 2007 Nov; 84(9):1082-91. PubMed ID: 17998861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How important is NK alloreactivity and KIR in allogeneic transplantation?
    Shaffer BC; Hsu KC
    Best Pract Res Clin Haematol; 2016 Dec; 29(4):351-358. PubMed ID: 27890259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of NK cells in allogeneic hematopoietic stem cell transplantation--review].
    Li XH; Gao CJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):845-8. PubMed ID: 16928336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.
    Giebel S; Nowak I; Dziaczkowska J; Czerw T; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Holowiecka-Goral A; Markiewicz M; Kopera M; Karolczyk A; Kyrcz-Krzemien S; Kusnierczyk P
    Eur J Haematol; 2009 Oct; 83(4):343-56. PubMed ID: 19500138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence factors of reconstitution of killer cell immunoglobulin-like receptor on NK cells following non-T-cell-depleted haploidentical hematopoietic stem cell transplantation].
    Zhao XY; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):103-6. PubMed ID: 17650670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.